PCN16 ADDING RITUXIMABTO STANDARD CHEMOTHERAPY APPEARS DOMINANT VS. CHEMOTHERAPY ALONE IN ADVANCED STAGE NHL—INTERIM RESULTS FROM A RANDOMIZED CLINICAL TRIAL (RCT)
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67254-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)67254-3/fulltext
Title :
PCN16 ADDING RITUXIMABTO STANDARD CHEMOTHERAPY APPEARS DOMINANT VS. CHEMOTHERAPY ALONE IN ADVANCED STAGE NHL—INTERIM RESULTS FROM A RANDOMIZED CLINICAL TRIAL (RCT)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67254-3&doi=10.1016/S1098-3015(10)67254-3
First page :
Section Title :
Open access? :
No
Section Order :
481